Institut de Cancérologie de l'Ouest - Site Paul Papin — Angers

Public research footprint of Institut de Cancérologie de l'Ouest - Site Paul Papin, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non Small Cell Lung Cancer · Cervix Cancer · Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)

Recently updated registry entries

NCT07237256 — Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated… (Recruiting)
NCT03870919 — Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2… (Active Not Recruiting)
NCT04912687 — Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut de Cancérologie de l'Ouest - Site Paul Papin?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.